A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

NCT02604017 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

703

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C
Hepatitis C Virus
HCV

Interventions

DRUG: ABT-493/ABT-530

Sponsor

AbbVie